The Global CD20 Monoclonal Antibodies Market is a pivotal segment of therapeutic biologics focused on treating CD20-positive hematological cancers and autoimmune diseases. CD20 monoclonal antibodies are engineered proteins that selectively target the CD20 antigen found on the surface of B-cells, enabling immune-mediated destruction of malignant or dysregulated cells. These therapies...